Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.

Phosphoinositide 3-kinase (PI3K) p85alpha-deficient mice exhibit hypoglycemia as a result of increased insulin sensitivity and glucose uptake in peripheral tissues. Although PI3K is central to the metabolic actions of insulin, its mechanism of action in liver is not well understood. In the present study, we investigated hepatic insulin signaling and glucose homeostasis in p85alpha-deficient and wild-type mice. In the livers of p85alpha-deficient mice, p50alpha played a compensatory role in insulin-stimulated PI3K activation by binding to insulin receptor substrate (IRS)-1/2. In p85alpha-deficient mice, the ratio of p50alpha over p110 catalytic subunit of PI3K in the liver was higher than in the muscles. PI3K activity associated with IRS-1/2 was not affected by the lack of p85alpha in the liver. Insulin-stimulated Akt and phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activities in the liver were similar in p85alpha-deficient and wild-type mice. A hyperinsulinemic-euglycemic clamp study revealed that the glucose infusion rate and the rate of disappearance were higher in p85alpha-deficient mice than in wild-type mice but that endogenous glucose production tended to be higher in p85alpha-deficient mice than in wild-type mice. Consistent with this finding, the expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in livers after fasting was higher in p85alpha-deficient mice than in wild-type mice. After mice were fasted, the intrahepatic glucose-6-phosphate level was almost completely depleted in p85alpha-deficient mice. The glycogen content fell to nearly zero as a result of glycogenolysis shortly after the initiation of fasting in p85alpha-deficient mice. The absence of an increase in insulin-stimulated PI3K activation in the liver of p85alpha-deficient mice, unlike the muscles, may be associated with the molecular balance between the regulatory subunit and the catalytic subunit of PI3K. Gluconeogenesis was rather elevated in p85alpha-deficient mice, compared with in wild-type mice, and the liver seemed to partially compensate for the increase in glucose uptake in peripheral tissues.

[1]  A. Cherrington,et al.  Autoregulation of hepatic glucose production. , 1998, European journal of endocrinology.

[2]  M. Birnbaum,et al.  Signaling Pathways Mediating Insulin‐Stimulated Glucose Transport , 1999, Annals of the New York Academy of Sciences.

[3]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[4]  T. Noda,et al.  Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways* , 2006, Journal of Biological Chemistry.

[5]  Simeon I. Taylor,et al.  Deconstructing Type 2 Diabetes , 1999, Cell.

[6]  H. Aburatani,et al.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.

[7]  Jens C. Brüning,et al.  The role of insulin receptor signaling in the brain , 2005, Trends in Endocrinology & Metabolism.

[8]  R. Bergman,et al.  Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity. , 2000, Diabetes.

[9]  M. White,et al.  Perspective: The Insulin Signaling System-A Common Link in the Pathogenesis of Type 2 Diabetes. , 2000, Endocrinology.

[10]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[11]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[12]  B. Vanhaesebroeck,et al.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers , 2007, Proceedings of the National Academy of Sciences.

[13]  R. O’Brien,et al.  Central Role for Phosphatidylinositide 3-Kinase in the Repression of Glucose-6-phosphatase Gene Transcription by Insulin* , 1998, The Journal of Biological Chemistry.

[14]  C. Kahn,et al.  Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. , 2006, Cell metabolism.

[15]  Kohjiro Ueki,et al.  Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. , 2002, The Journal of clinical investigation.

[16]  M. Kasuga,et al.  From receptor to transporter: insulin signalling to glucose transport , 1997, Diabetologia.

[17]  Y. Matsuzawa,et al.  Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.

[18]  Y. Yazaki,et al.  A Novel 55-kDa Regulatory Subunit for Phosphatidylinositol 3-Kinase Structurally Similar to p55PIK Is Generated by Alternative Splicing of the p85 Gene (*) , 1996, The Journal of Biological Chemistry.

[19]  K. Okkenhaug,et al.  New Responsibilities for the PI3K Regulatory Subunit p85α , 2001, Science's STKE.

[20]  T. Noda,et al.  Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. , 2004, The Journal of clinical investigation.

[21]  C. Kahn,et al.  Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN , 2006, Proceedings of the National Academy of Sciences.

[22]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[23]  C. Kahn,et al.  p50α/p55α Phosphoinositide 3-Kinase Knockout Mice Exhibit Enhanced Insulin Sensitivity , 2004, Molecular and Cellular Biology.

[24]  T. Asano,et al.  Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver , 2008, Science.

[25]  S. Aizawa,et al.  Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase. , 2004, Diabetes.

[26]  Kohjiro Ueki,et al.  Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. , 2007, Cell metabolism.

[27]  T. Kodama,et al.  Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. , 1997, The Journal of clinical investigation.

[28]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[29]  N. Sonenberg,et al.  Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice , 1996, Molecular and cellular biology.

[30]  H. Taniguchi,et al.  Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice. , 2004, Life sciences.

[31]  L. Cantley,et al.  Structural Organization and Alternative Splicing of the Murine Phosphoinositide 3-Kinase p85α Gene , 1996 .

[32]  Y. Yazaki,et al.  p85α Gene Generates Three Isoforms of Regulatory Subunit for Phosphatidylinositol 3-Kinase (PI 3-Kinase), p50α, p55α, and p85α, with Different PI 3-Kinase Activity Elevating Responses to Insulin* , 1997, The Journal of Biological Chemistry.

[33]  J. M. Agati,et al.  Assessment of the Roles of Mitogen-activated Protein Kinase, Phosphatidylinositol 3-Kinase, Protein Kinase B, and Protein Kinase C in Insulin Inhibition of cAMP-induced Phosphoenolpyruvate Carboxykinase Gene Transcription* , 1998, The Journal of Biological Chemistry.

[34]  S. Rous.  Effect of insulin on incorporation of 14C-labeled pyruvates and bicarbonate into blood glucose of fasted mice. , 1978, The American journal of physiology.

[35]  F. Alt,et al.  Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.

[36]  C. Kahn,et al.  Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain , 1996, Molecular and cellular biology.

[37]  T. Fujiwara,et al.  Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL KsJ-db db mice , 1995 .

[38]  G. Lienhard,et al.  The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[39]  C. Kahn,et al.  Positive and Negative Regulation of Phosphoinositide 3-Kinase-Dependent Signaling Pathways by Three Different Gene Products of the p85α Regulatory Subunit , 2000, Molecular and Cellular Biology.

[40]  Kohjiro Ueki,et al.  Molecular Balance between the Regulatory and Catalytic Subunits of Phosphoinositide 3-Kinase Regulates Cell Signaling and Survival , 2002, Molecular and Cellular Biology.

[41]  G. Mithieux,et al.  Liver Microsomal Glucose-6-phosphatase Is Competitively Inhibited by the Lipid Products of Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[42]  R. O’Brien,et al.  Phosphatidylinositol 3-Kinase, but Not p70/p85 Ribosomal S6 Protein Kinase, Is Required for the Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression by Insulin , 1995, The Journal of Biological Chemistry.

[43]  M. Matsuhisa,et al.  Both Insulin Signaling Defects in the Liver and Obesity Contribute to Insulin Resistance and Cause Diabetes in Irs2–/– Mice* , 2004, Journal of Biological Chemistry.

[44]  T. Noda,et al.  Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. , 2008, Cell metabolism.

[45]  Y. Yazaki,et al.  Signal transduction mechanism of insulin and insulin-like growth factor-1. , 1996, Endocrine journal.

[46]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .